Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy.
Venglar O, Kapustova V, Anilkumar Sithara A, Zihala D, Muronova L, Sevcikova T, Vrana J, Vdovin A, Radocha J, Krhovska P, Hrdinka M, Turjap M, Popkova T, Chyra Z, Broskevicova L, Simicek M, Koristek Z, Hajek R, Jelinek T. Venglar O, et al. Among authors: hrdinka m. Br J Haematol. 2024 Apr;204(4):1439-1449. doi: 10.1111/bjh.19141. Epub 2023 Oct 9. Br J Haematol. 2024. PMID: 37807708
Venetoclax: A new wave in hematooncology.
Mihalyova J, Jelinek T, Growkova K, Hrdinka M, Simicek M, Hajek R. Mihalyova J, et al. Among authors: hrdinka m. Exp Hematol. 2018 May;61:10-25. doi: 10.1016/j.exphem.2018.02.002. Epub 2018 Mar 2. Exp Hematol. 2018. PMID: 29477371 Free article. Review.
Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis.
Chyra Z, Sevcikova T, Vojta P, Puterova J, Brozova L, Growkova K, Filipova J, Zatopkova M, Grosicki S, Barchnicka A, Jedrzejczak WW, Waszczuk-Gajda A, Jungova A, Mikulasova A, Hajduch M, Mokrejs M, Pour L, Stork M, Harvanova L, Mistrik M, Mikala G, Robak P, Czyz A, Debski J, Usnarska-Zubkiewicz L, Jurczyszyn A, Stejskal L, Morgan G, Kryukov F, Budinska E, Simicek M, Jelinek T, Hrdinka M, Hajek R. Chyra Z, et al. Among authors: hrdinka m. Haematologica. 2021 Feb 1;106(2):601-604. doi: 10.3324/haematol.2019.239756. Haematologica. 2021. PMID: 32381580 Free PMC article. No abstract available.
A Bird's-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers.
Motais B, Charvátová S, Hrdinka M, Šimíček M, Jelínek T, Ševčíková T, Kořístek Z, Hájek R, Bagó JR. Motais B, et al. Among authors: hrdinka m. Cancers (Basel). 2020 May 23;12(5):1333. doi: 10.3390/cancers12051333. Cancers (Basel). 2020. PMID: 32456165 Free PMC article. Review.
Intercellular Mitochondrial Transfer in the Tumor Microenvironment.
Sahinbegovic H, Jelinek T, Hrdinka M, Bago JR, Turi M, Sevcikova T, Kurtovic-Kozaric A, Hajek R, Simicek M. Sahinbegovic H, et al. Among authors: hrdinka m. Cancers (Basel). 2020 Jul 4;12(7):1787. doi: 10.3390/cancers12071787. Cancers (Basel). 2020. PMID: 32635428 Free PMC article. Review.
Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment.
Motais B, Charvátová S, Walek Z, Hrdinka M, Smolarczyk R, Cichoń T, Czapla J, Giebel S, Šimíček M, Jelínek T, Ševčíková T, Sobotka J, Kořístek Z, Hájek R, Bagó JR. Motais B, et al. Among authors: hrdinka m. Cells. 2021 Apr 21;10(5):967. doi: 10.3390/cells10050967. Cells. 2021. PMID: 33919155 Free PMC article.
Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine.
Zátopková M, Ševčíková T, Fanfani V, Chyra Z, Říhová L, Bezděková R, Žihala D, Growková K, Filipová J, Černá L, Broskevičova L, Kryukov F, Minařík J, Smejkalová J, Maisnar V, Harvanová Ĺ, Pour L, Jungova A, Popková T, Bago JR, Anilkumar Sithara A, Hrdinka M, Jelínek T, Šimíček M, Stracquadanio G, Hájek R. Zátopková M, et al. Among authors: hrdinka m. Blood Adv. 2022 Jan 25;6(2):368-372. doi: 10.1182/bloodadvances.2020003876. Blood Adv. 2022. PMID: 34500459 Free PMC article. No abstract available.
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma.
Jelinek T, Bezdekova R, Zihala D, Sevcikova T, Anilkumar Sithara A, Pospisilova L, Sevcikova S, Polackova P, Stork M, Knechtova Z, Venglar O, Kapustova V, Popkova T, Muronova L, Chyra Z, Hrdinka M, Simicek M, Garcés JJ, Puig N, Cedena MT, Jurczyszyn A, Castillo JJ, Penka M, Radocha J, Mateos MV, San-Miguel JF, Paiva B, Pour L, Rihova L, Hajek R. Jelinek T, et al. Among authors: hrdinka m. J Clin Oncol. 2023 Mar 1;41(7):1383-1392. doi: 10.1200/JCO.22.01226. Epub 2022 Oct 31. J Clin Oncol. 2023. PMID: 36315921 Free PMC article.
31 results